| 1 |
Yue C, Feng S, Chen Y, Jing N. The therapeutic prospects and challenges of human neural stem cells for the treatment of Alzheimer's Disease. Cell Regen 2022;11:28. [DOI: 10.1186/s13619-022-00128-5] [Reference Citation Analysis]
|
| 2 |
Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer's disease: a review. 3 Biotech 2022;12:55. [PMID: 35116217 DOI: 10.1007/s13205-022-03123-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 3 |
Luciani M, Garsia C, Mangiameli E, Meneghini V, Gritti A. Intracerebroventricular transplantation of human iPSC-derived neural stem cells (hiPSC-NSCs) into neonatal mice. Methods in Cell Biology 2022. [DOI: 10.1016/bs.mcb.2022.04.007] [Reference Citation Analysis]
|
| 4 |
Salwa, Kumar L. Engrafted stem cell therapy for Alzheimer's disease: A promising treatment strategy with clinical outcome. J Control Release 2021;338:837-57. [PMID: 34509587 DOI: 10.1016/j.jconrel.2021.09.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 5 |
Zhao L, Liu JW, Shi HY, Ma YM. Neural stem cell therapy for brain disease. World J Stem Cells 2021; 13(9): 1278-1292 [PMID: 34630862 DOI: 10.4252/wjsc.v13.i9.1278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 6 |
Chan HJ, Yanshree, Roy J, Tipoe GL, Fung ML, Lim LW. Therapeutic Potential of Human Stem Cell Implantation in Alzheimer's Disease. Int J Mol Sci 2021;22:10151. [PMID: 34576314 DOI: 10.3390/ijms221810151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 7 |
Zheng J, Li Y. Compensation for Neurodegeneration by Hippocampal Neurogenesis in Alzheimer's Disease: Where is the Way? Neurosci Bull 2021;37:885-8. [PMID: 33905098 DOI: 10.1007/s12264-021-00660-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Si Z, Wang X. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling. J Pharmacol Exp Ther 2021;377:207-17. [PMID: 33558427 DOI: 10.1124/jpet.120.000324] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 9 |
Liu XY, Yang LP, Zhao L. Stem cell therapy for Alzheimer's disease. World J Stem Cells 2020; 12(8): 787-802 [PMID: 32952859 DOI: 10.4252/wjsc.v12.i8.787] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 10 |
Chen Q, Song H, Liu C, Xu J, Wei C, Wang W, Han F. The Interaction of EphA4 With PDGFRβ Regulates Proliferation and Neuronal Differentiation of Neural Progenitor Cells in vitro and Promotes Neurogenesis in vivo. Front Aging Neurosci 2020;12:7. [PMID: 32116646 DOI: 10.3389/fnagi.2020.00007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 11 |
Hayashi Y, Lin HT, Lee CC, Tsai KJ. Effects of neural stem cell transplantation in Alzheimer's disease models. J Biomed Sci 2020;27:29. [PMID: 31987051 DOI: 10.1186/s12929-020-0622-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 12 |
Zhang FQ, Jiang JL, Zhang JT, Niu H, Fu XQ, Zeng LL. Current status and future prospects of stem cell therapy in Alzheimer's disease. Neural Regen Res 2020;15:242-50. [PMID: 31552889 DOI: 10.4103/1673-5374.265544] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 13 |
Vasic V, Barth K, Schmidt MHH. Neurodegeneration and Neuro-Regeneration-Alzheimer's Disease and Stem Cell Therapy. Int J Mol Sci 2019;20:E4272. [PMID: 31480448 DOI: 10.3390/ijms20174272] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 14 |
Najm R, Jones EA, Huang Y. Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease. Mol Neurodegener 2019;14:24. [PMID: 31186040 DOI: 10.1186/s13024-019-0324-6] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 15 |
Guo Y, Li X, Zhang M, Chen N, Wu S, Lei J, Wang Z, Wang R, Wang J, Liu H. Age‑ and brain region‑associated alterations of cerebral blood flow in early Alzheimer's disease assessed in AβPPSWE/PS1ΔE9 transgenic mice using arterial spin labeling. Mol Med Rep 2019;19:3045-52. [PMID: 30816468 DOI: 10.3892/mmr.2019.9950] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Ma Y, Wang K, Pan J, Fan Z, Tian C, Deng X, Ma K, Xia X, Huang Y, Zheng JC. Induced neural progenitor cells abundantly secrete extracellular vesicles and promote the proliferation of neural progenitors via extracellular signal-regulated kinase pathways. Neurobiol Dis 2019;124:322-34. [PMID: 30528256 DOI: 10.1016/j.nbd.2018.12.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 17 |
Shen Z, Lei J, Li X, Wang Z, Bao X, Wang R. Multifaceted assessment of the APP/PS1 mouse model for Alzheimer's disease: Applying MRS, DTI, and ASL. Brain Res 2018;1698:114-20. [PMID: 30077647 DOI: 10.1016/j.brainres.2018.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 18 |
Tang Y, Yu P, Cheng L. Current progress in the derivation and therapeutic application of neural stem cells. Cell Death Dis 2017;8:e3108. [PMID: 29022921 DOI: 10.1038/cddis.2017.504] [Cited by in Crossref: 92] [Cited by in F6Publishing: 97] [Article Influence: 15.3] [Reference Citation Analysis]
|
